ConvaTec Regulatory News (CTEC)

Special Resolutions available at NSM

11 May 2018

ConvaTec Group Plc

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting on 10 May 2018 and the results of the poll were published that day.

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the annual general meeting have been submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.

For further information, please contact Clare Bates, Company Secretary (0118 952 8100).

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

Enquiries

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435

Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582

investorrelations@convatec.com

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226

Rebecca Fitchett, Finsbury +44 (0)207 251 3801

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END